Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Zeiser

Showing results (91-100 of 373) with videos related to

Pageof 38
Sort By:
Immunology|June 12, 2012
Graft-versus-host disease reduces regulatory T-cell migration into the tumour tissueChristoph Dürr, Marie Follo, Marco Idzko, et al.
Stem Cell Reviews|November 30, 2006
Stem cell plasticity: the debate begins to clarifyAlexandros Spyridonidis, Robert Zeiser, Marie Follo, et al.
Leukemia|March 27, 2025
Malignant JAK-signaling: at the interface of inflammation and malignant transformationFlorian Perner, Heike L Pahl, Robert Zeiser, et al.
Clinical Transplantation|May 10, 2005
Capillary electrophoresis for chimerism monitoring by PCR amplification of microsatellite markers after allogeneic hematopoietic cell transplantationAlexandros Spyridonidis, Robert Zeiser, Ralph Wäsch, et al.
Current Stem Cell Research & Therapy|February 15, 2012
Immunotherapy for malignant melanomaRobert Zeiser, Marc Schnitzler, Hana Andrlova, et al.
The Journal of Clinical Investigation|June 8, 2021
Insights from integrating clinical and preclinical studies advance understanding of graft-versus-host diseaseGérard Socié, Leslie S Kean, Robert Zeiser, et al.
Frontiers in Molecular Biosciences|March 28, 2024
Editorial: Transcriptional and epigenetic regulation in normal and aberrant hematopoiesisJonas S Jutzi, Ruud Delwel, Robert Zeiser, et al.
British Journal of Haematology|March 25, 2023
Pathophysiology of gastrointestinal acute graft-versus-host disease and the potential role of glucagon-like peptide 2Robert Zeiser, Yi-Bin Chen, Nader N Youssef, et al.
Immunotherapy|May 29, 2025
Biology-driven therapies of CAR T immune effector cell-associated neurotoxicity syndromeSophie Giesler, Francesca Biavasco, Tobias Wertheimer, et al.
Lancet (London, England)|January 26, 2026
BCMA-CD3 T-cell engager as salvage therapy for multirefractory primary immune thrombocytopeniaJesus Duque-Afonso, Christoph Rummelt, Katharina Förster, et al.
Pageof 38

Showing results (91-100 of 373) with videos related to

Sort By:
Pageof 38
Immunology|June 12, 2012
Graft-versus-host disease reduces regulatory T-cell migration into the tumour tissueChristoph Dürr, Marie Follo, Marco Idzko, et al.
Stem Cell Reviews|November 30, 2006
Stem cell plasticity: the debate begins to clarifyAlexandros Spyridonidis, Robert Zeiser, Marie Follo, et al.
Leukemia|March 27, 2025
Malignant JAK-signaling: at the interface of inflammation and malignant transformationFlorian Perner, Heike L Pahl, Robert Zeiser, et al.
Clinical Transplantation|May 10, 2005
Capillary electrophoresis for chimerism monitoring by PCR amplification of microsatellite markers after allogeneic hematopoietic cell transplantationAlexandros Spyridonidis, Robert Zeiser, Ralph Wäsch, et al.
Current Stem Cell Research & Therapy|February 15, 2012
Immunotherapy for malignant melanomaRobert Zeiser, Marc Schnitzler, Hana Andrlova, et al.
The Journal of Clinical Investigation|June 8, 2021
Insights from integrating clinical and preclinical studies advance understanding of graft-versus-host diseaseGérard Socié, Leslie S Kean, Robert Zeiser, et al.
Frontiers in Molecular Biosciences|March 28, 2024
Editorial: Transcriptional and epigenetic regulation in normal and aberrant hematopoiesisJonas S Jutzi, Ruud Delwel, Robert Zeiser, et al.
British Journal of Haematology|March 25, 2023
Pathophysiology of gastrointestinal acute graft-versus-host disease and the potential role of glucagon-like peptide 2Robert Zeiser, Yi-Bin Chen, Nader N Youssef, et al.
Immunotherapy|May 29, 2025
Biology-driven therapies of CAR T immune effector cell-associated neurotoxicity syndromeSophie Giesler, Francesca Biavasco, Tobias Wertheimer, et al.
Lancet (London, England)|January 26, 2026
BCMA-CD3 T-cell engager as salvage therapy for multirefractory primary immune thrombocytopeniaJesus Duque-Afonso, Christoph Rummelt, Katharina Förster, et al.
Pageof 38